Cargando…

An Inter‐Cooperative Biohybrid Platform to Enable Tumor Ablation and Immune Activation

A biohybrid therapeutic system, consisting of responsive materials and living microorganisms with inter‐cooperative effects, is designed and investigated for tumor treatment. In this biohybrid system, S(2)O(3) (2−)‐intercalated CoFe layered double hydroxides (LDH) are integrated at the surface of Ba...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Feiyu, Chu, Qiang, Hu, Zefeng, Lu, Zijie, Fang, Chao, Han, Gaorong, Fu, Yike, Li, Xiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427385/
https://www.ncbi.nlm.nih.gov/pubmed/37314157
http://dx.doi.org/10.1002/advs.202207194
_version_ 1785090227108315136
author Li, Feiyu
Chu, Qiang
Hu, Zefeng
Lu, Zijie
Fang, Chao
Han, Gaorong
Fu, Yike
Li, Xiang
author_facet Li, Feiyu
Chu, Qiang
Hu, Zefeng
Lu, Zijie
Fang, Chao
Han, Gaorong
Fu, Yike
Li, Xiang
author_sort Li, Feiyu
collection PubMed
description A biohybrid therapeutic system, consisting of responsive materials and living microorganisms with inter‐cooperative effects, is designed and investigated for tumor treatment. In this biohybrid system, S(2)O(3) (2−)‐intercalated CoFe layered double hydroxides (LDH) are integrated at the surface of Baker's yeasts. Under the tumor microenvironment, functional interactions between yeast and LDH are effectively triggered, resulting in S(2)O(3) (2−) release, H(2)S production, and in‐situ generation of highly catalytic agents. Meanwhile, the degradation of LDH in the tumor microenvironment induces the exposure of the surface antigen of yeast, leading to effective immune activation at the tumor site. By virtue of the inter‐cooperative phenomena, this biohybrid system exhibits significant efficacy in tumor ablation and strong inhibition of recurrence. This study has potentially offered an alternative concept by utilizing the metabolism of living microorganisms and materials in exploring effective tumor therapeutics.
format Online
Article
Text
id pubmed-10427385
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-104273852023-08-17 An Inter‐Cooperative Biohybrid Platform to Enable Tumor Ablation and Immune Activation Li, Feiyu Chu, Qiang Hu, Zefeng Lu, Zijie Fang, Chao Han, Gaorong Fu, Yike Li, Xiang Adv Sci (Weinh) Research Articles A biohybrid therapeutic system, consisting of responsive materials and living microorganisms with inter‐cooperative effects, is designed and investigated for tumor treatment. In this biohybrid system, S(2)O(3) (2−)‐intercalated CoFe layered double hydroxides (LDH) are integrated at the surface of Baker's yeasts. Under the tumor microenvironment, functional interactions between yeast and LDH are effectively triggered, resulting in S(2)O(3) (2−) release, H(2)S production, and in‐situ generation of highly catalytic agents. Meanwhile, the degradation of LDH in the tumor microenvironment induces the exposure of the surface antigen of yeast, leading to effective immune activation at the tumor site. By virtue of the inter‐cooperative phenomena, this biohybrid system exhibits significant efficacy in tumor ablation and strong inhibition of recurrence. This study has potentially offered an alternative concept by utilizing the metabolism of living microorganisms and materials in exploring effective tumor therapeutics. John Wiley and Sons Inc. 2023-06-14 /pmc/articles/PMC10427385/ /pubmed/37314157 http://dx.doi.org/10.1002/advs.202207194 Text en © 2023 The Authors. Advanced Science published by Wiley‐VCH GmbH https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Li, Feiyu
Chu, Qiang
Hu, Zefeng
Lu, Zijie
Fang, Chao
Han, Gaorong
Fu, Yike
Li, Xiang
An Inter‐Cooperative Biohybrid Platform to Enable Tumor Ablation and Immune Activation
title An Inter‐Cooperative Biohybrid Platform to Enable Tumor Ablation and Immune Activation
title_full An Inter‐Cooperative Biohybrid Platform to Enable Tumor Ablation and Immune Activation
title_fullStr An Inter‐Cooperative Biohybrid Platform to Enable Tumor Ablation and Immune Activation
title_full_unstemmed An Inter‐Cooperative Biohybrid Platform to Enable Tumor Ablation and Immune Activation
title_short An Inter‐Cooperative Biohybrid Platform to Enable Tumor Ablation and Immune Activation
title_sort inter‐cooperative biohybrid platform to enable tumor ablation and immune activation
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427385/
https://www.ncbi.nlm.nih.gov/pubmed/37314157
http://dx.doi.org/10.1002/advs.202207194
work_keys_str_mv AT lifeiyu anintercooperativebiohybridplatformtoenabletumorablationandimmuneactivation
AT chuqiang anintercooperativebiohybridplatformtoenabletumorablationandimmuneactivation
AT huzefeng anintercooperativebiohybridplatformtoenabletumorablationandimmuneactivation
AT luzijie anintercooperativebiohybridplatformtoenabletumorablationandimmuneactivation
AT fangchao anintercooperativebiohybridplatformtoenabletumorablationandimmuneactivation
AT hangaorong anintercooperativebiohybridplatformtoenabletumorablationandimmuneactivation
AT fuyike anintercooperativebiohybridplatformtoenabletumorablationandimmuneactivation
AT lixiang anintercooperativebiohybridplatformtoenabletumorablationandimmuneactivation
AT lifeiyu intercooperativebiohybridplatformtoenabletumorablationandimmuneactivation
AT chuqiang intercooperativebiohybridplatformtoenabletumorablationandimmuneactivation
AT huzefeng intercooperativebiohybridplatformtoenabletumorablationandimmuneactivation
AT luzijie intercooperativebiohybridplatformtoenabletumorablationandimmuneactivation
AT fangchao intercooperativebiohybridplatformtoenabletumorablationandimmuneactivation
AT hangaorong intercooperativebiohybridplatformtoenabletumorablationandimmuneactivation
AT fuyike intercooperativebiohybridplatformtoenabletumorablationandimmuneactivation
AT lixiang intercooperativebiohybridplatformtoenabletumorablationandimmuneactivation